The plunger fits snugly within the barrel, creating a seal that allows for precise control of insulin flow
Veljaca M, Lesch CA, Pllana R, Sanchez B, Chan K, Guglietta A
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
A triple agonist activates three different receptors simultaneously
Produced using established synthetic peptide manufacturing methods, it is supplied as a white to off-white lyophilized powder consistent with the expected physicochemical characteristics of high-purity research peptides